IRWD Ironwood Pharmaceuticals, Inc.
$4.08▲ +2.77%
Healthcare
Other
After hours
$3.99▼ -2.26%
Sep 11, 7:30 PM ET
Volume 1.25M
Avg Volume (10D) 1.49M
Key Metrics & Fundamentals
Market Cap
$674.18M
P/E Ratio
5.2
Div Yield
–%
52W Range
1.23 - 5.78
% vs 50 MA
-2.07%
% vs 200 MA
3.17%
RSI-14
46.8
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.99
Free Cash Flow
$58.28M
Gross Rev
$113.04M
Gross Profit
$113.04M
EBITDA
$81.39M
COGS
–
Operating Exp
$33.73M
Operating Income
$79.31M
EBIT
$79.31M
Pretax Income
$73.73M
Net Income
$51.29M
EPS (Diluted)
0.31
Price & Volume History
Loading chart…
Recent News
Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference
Business Wire · Sep 3, 2026 8:05 PM
Ironwood (IRWD) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 5:43 PM
Ironwood Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 12:30 PM
Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed?
Simply Wall St. · Aug 7, 2026 4:31 AM
Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call Highlights: Strong LINZESS Growth ...
GuruFocus.com · Aug 6, 2026 11:16 PM
Ironwood Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 8:04 PM
Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates
Zacks · Aug 6, 2026 1:50 PM
Ironwood: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 11:21 AM
Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results
Business Wire · Aug 6, 2026 11:05 AM
Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call
Business Wire · Jul 30, 2026 8:05 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See IRWD's money flow as a full page
Social Sentiment
Avg +1.00 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.